series-b
Stage
1
Investors
About
Orionis Biosciences is a clinical-stage life sciences company developing novel precision medicines that modulate protein-protein, protein-cell, and cell-cell interactions using molecular glues, cytokines, and cell engagers to target cancer and enhance immune responses.
Explore Orionis Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.